A novel combination (“CHAP”) regimen for management of livedoid vasculopathy in 12 patients
收藏官方服务：
资源简介：
Figure 1. Representative before (A) and after (B) images of patient 11 three months after initiation of the "CHAP" regimen (and discontinuation of prednisone and sulfasalazine), showing resolution of painful ulcerations and jagged purpuric macules without formation of new lesions.
提供机构：
Mendeley创建时间：
2022-06-16
